Co-morbidity of bronchial asthma and metabolic syndrome: possibilities to achieve asthma control
https://doi.org/10.18093/0869-0189-2014-0-5-39-45
Abstract
Aim. The aim of this study was to evaluate clinical efficacy of a rehabilitation program for patients with bronchial asthma (BA) and comorbid metabolic syndrome (MS).
Methods. This randomized study involved 60 stable patients (15 males) with moderate BA and comorbid MS. The mean age of the participants was 49.81 ± 0.77 years. BA was diagnosed according to GINA, 2011. The patients randomly received standard medication therapy plus education and physical training or standard therapy only. Clinical symptoms of BA, lung function, quality of life and nutritional status were assessed at baseline and in 12 months.
Results. In 12 months, patients treated with rehabilitation program in addition to the standard therapy have demonstrated significant improvement in all parameters in comparison to patients treated with standard therapy only.
Conclusion. Implementation of this program focused on education and physical training was related to a significant reduction in BA exacerbation rate, number of emergency calls and hospitalizations due to BA, decrease in severity of daytime and nighttime asthma symptoms, improvement in lung function, and achievement the optimal BA control.
About the Authors
A. V. Budnevskiy
State Institute N.N.Burdenko Voronezh Medical Academy; Voronezh, Russia
Russian Federation
Russian Federation
A. V. Chernov
State Institute N.N.Burdenko Voronezh Medical Academy; Voronezh, Russia
Voronezh Clinical Emergency Hospital N 1; Voronezh, Russia
Russian Federation
Russian Federation
A. V. Ermolova
State Institute N.N.Burdenko Voronezh Medical Academy; Voronezh, Russia
Russian Federation
Russian Federation
L. V. Tribuntseva
State Institute N.N.Burdenko Voronezh Medical Academy; Voronezh, Russia
Russian Federation
Russian Federation
References
1. Global Strategy for Asthma Management and Preven tion, Global Initiative for Asthma. UPDATED 2011. www.ginasthma.org
2. Tribuntseva L.V., Budnevskiy A.V., Razvorotnev A.V. Systemic approach to management of bronchial asthma. Vrachaspirant. 2012; 1.2 (5): 338–342 (in Russian).
3. Malyavin A.G., Epifanov V.A., Glazkova I.I. Pulmonary Rehabilitation. Moscow: GEOTARMedia; 2010 (in Russian).
4. Sysoeva M.S., Solov'eva A.V., Nikiforov A.A. et al. An influence of metabolic syndrome on clinical course of bronchial asthma. Rossiyskiy medikobiologicheskiy vestnik imeniakademika I.P.Pavlova. 2011; 4: 100–105 (in Russian).
5. Roytberg G.E. Metabolic Syndrome. Moscow: MEDpress inform; 2007 (in Russian).
6. Uryas'ev O.M., Panfilov Yu.A. Bronchial asthma and metabolic syndrome: some aspects of comorbidity. Mezhdu narodnyy endokrinologicheskiy zhurnal. 2008; 3 (15): 20–24 (in Russian).
7. Appleton S.L., Ruffin R.E., Wilson D.H. et al. Asthma is associated with cardiovascular disease in a representative population sample. Obes. Res. Clin. Pract. 2008; 2 (2): 71–142.
8. Assad N., Qualls C., Smith L.J. Body mass index is a stronger predictor than the metabolic syndrome for future asthma in women. The longitudinal CARDIA study. Am. J. Respir. Crit. Care Med. 2013; 188 (3): 319–326.
9. Kruglov V.I. Bronchial Asthma. St. Petersburg: Severo-Zapad; 2005 (in Russian).
10. Recommendations of Experts of Russian Scientific Society of Cardiologists on Diagnosis and Treatment of Metabolic Syndrome. Moscow; 2009 (in Russian).
Review
For citations:
Budnevskiy A.V., Chernov A.V., Ermolova A.V., Tribuntseva L.V. Co-morbidity of bronchial asthma and metabolic syndrome: possibilities to achieve asthma control. PULMONOLOGIYA. 2014;(5):39-45. (In Russ.) https://doi.org/10.18093/0869-0189-2014-0-5-39-45
Views:
1079
Email this article 